Assent of this stock stated with a misplaced flattering piece in Barron’s. Investors seem to think that ANAD’s Gallium Arsenide technology is a new big innovation — but these investors are wrong. There is nothing new or magical about this technology that has happened recently. The technology has been around for a while.
Start shorting gingerly here and become aggressive if the stock moves into mid twenties or if the money flow becomes consistently negative. ANAD may have good quarters and good newses, but expect the stock to visit mid single digits where it was before Barron’s highly promotional article.
